Uncategorized

Uncategorized Published - 3 September, 2019    By - Dr Clemens
Point-of-Care Ultrasound Abnormalities in Late-Onset Severe Preeclampsia: Prevalence and Association With Serum Albumin and Brain Natriuretic Peptide

AUTHORS: Ortner, Clemens M. Priv Doz et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1208-1216 BACKGROUND: Pilot studies applying point-of-care ultrasound (POCUS) in preeclampsia indicate the presence of pulmonary interstitial edema, cerebral edema, and cardiac dysfunction. Laboratory markers of oncotic pressure (albumin) and cardiac dysfunction (brain natriuretic peptide [BNP]) […]

Read More
Uncategorized Published - 3 September, 2019    By - Dr Clemens
Popular pain medication associated with greater risk of hypoglycemia

Author: Heather Buschman, PhD. Science Daily Summary: As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar. Since its approval in 1995, the opioid tramadol (marketed as ConZip […]

Read More
Uncategorized Published - 3 September, 2019    By - Dr Clemens
Boom in overdose-reversing drug is tied to fewer drug deaths

Author: MIKE STOBBE Prescriptions of the overdose-reversing drug naloxone are soaring, and experts say that could be a reason overdose deaths have stopped rising for the first time in nearly three decades. The number of naloxone prescriptions dispensed by U.S. retail pharmacies doubled from 2017 to last year, rising from 271,000 to 557,000, health officials […]

Read More
Uncategorized Published - 2 September, 2019    By - Dr Clemens
We wish all of our readers a Fun and Safe Labor Day

We will have our thoughts and prayers out to our readers in FL, GA and SC due to the hurricane fast approaching.  Please be safe and take caution.

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis

AUTHORS: Candiotti, Keith A. MD et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1098-1105 BACKGROUND: Postoperative nausea and vomiting (PONV) occurs commonly in surgical patients despite widespread prophylactic antiemetic use. Rescue options are currently limited. 5HT3 antagonists are most frequently used for prophylaxis, but if they fail, additional doses are […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Impact of 2 Distinct Levels of Mean Arterial Pressure on Near-Infrared Spectroscopy During Cardiac Surgery

AUTHORS: Holmgaard, Frederik BMSc et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1081-1088 BACKGROUND: Near-infrared spectroscopy (NIRS) is used worldwide to monitor regional cerebral oxygenation (rScO2) during cardiopulmonary bypass (CPB). Intervention protocols meant to mitigate cerebral desaturation advocate to increase mean arterial pressure (MAP) when cerebral desaturation occurs. However, […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Gabapentinoid Medications Might Not Be as Benign as You Think

 Authors: Molero Y et al.  BMJ 2019 Jun 12 Multiple adverse behavioral and psychomotor associations are found with these drugs although the effects might be confined to pregabalin. Clinicians often prescribe gabapentin and pregabalin for pain, sleep, and anxiety symptoms, and some view these drugs as safe alternatives to benzodiazepines and opioids in, for example, patients […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time

AUTHORS: Benzon, Honorio T. MD et al Anesthesia & Analgesia: June 2019 – Volume 128 – Issue 6 – p 1089-1096 BACKGROUND: Patients presenting for surgery may have isolated or combined prolonged activated partial thromboplastin time (aPTT) and/or prothrombin time (PT). In patients not receiving anticoagulants or with no identifiable cause for abnormal clot formation, a […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
One-Third of Pre-Approved Drugs Haven’t Completed FDA Approval Process

I thought this was interesting so I wanted to share it with our readers. By Mark Terry BioSpace In 1992, the U.S. Food and Drug Administration (FDA) developed its Accelerated Approval Program. It was designed to move certain new drugs to the market faster. The Accelerated Approval leans on a surrogate endpoint, which is a marker, such as […]

Read More
Uncategorized Published - 30 August, 2019    By - Dr Clemens
NSAID use for osteoarthritis may bring on cardiovascular disease

Author: Tauren Dyson People with osteoarthritis who take NSAIDs have a 23 percent higher likelihood of developing cardiac disease compared to people without the condition. File Photo by Kzenon/Shutterstock Nonsteroidal anti-inflammatory drugs that treat inflammation and pain raise the risk of congenital heart disease, heart attack and other conditions for people with osteoarthritis, new findings […]

Read More